Average Co-Inventor Count = 1.24
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Gilead Sciences, Inc. (10 from 924 patents)
2. Cardeas Pharma Corporation (10 from 10 patents)
3. Corus Pharma, Inc. (3 from 5 patents)
4. Savara Inc. (2 from 5 patents)
5. Chiron Corporation (1 from 672 patents)
6. Salus Pharma, Inc. (1 from 1 patent)
27 patents:
1. 10471083 - Formulations of aminoglycoside and fosfomycin in combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
2. 10406171 - Formulations of aminoglycosides and fosfomycin in a combination having improved chemical properties
3. 9533000 - Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
4. 9526695 - Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
5. 9526696 - Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
6. 9526697 - Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
7. 9526698 - Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
8. 9486462 - Formulations of aminoglycosides and fosfomycin in a combination having improved chemical properties
9. 9345663 - Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
10. 8841286 - Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
11. 8826904 - Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
12. 8820323 - Methods to administer formulations of aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
13. 8636984 - Aerosol formulation of aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
14. 8636983 - Aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
15. 8603439 - Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis